MedTrace Logo

Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study

NCT06597864 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-12-09

No results posted yet for this study

Summary

The goal of this clinical pilot study is to learn how adults with schizophrenia or other non-affective psychotic disorders or psychosis risk syndromes experience a novel psychotherapeutic treatment for self-disorders. The study has a qualitative, phenomenological research design. After end of treatment, the participants are interviewed about the experience of the treatment. This include how the participants liked it, if it was experienced as helpful and useful, and changes in self-experience and experience of relations to others and the world.

Conditions

  • Psychosis;Schizophrenic

Interventions

BEHAVIORAL

Seven-step phenomenological psychotherapy for self-disorders

Phenomenological exploration of anomalous self-experiences, meaning attributions and behavioral consequences. Psychoeducation. Dialogical approach focusing on self-narratives, searching for new meaning and understanding of self-disorders

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Tor Gunnar Værnes, Dr.philos. · Oslo University Hospital, Early Intervention in Psychosis Advisory Unit for South-East Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-17
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597864 on ClinicalTrials.gov